Comparison of efficacy and safety of once- versus twice-daily insulin detemir added on to oral antidiabetics in insulin-naive type 2 diabetes patients: 24-week, crossover, treat to target trial in a single center

To compare once- versus twice-daily insulin detemir added on OADS therapy in insulin-naive type 2 diabetes patients in terms of efficacy and safety.

Source: Primary Care Diabetes - February 11, 2014 Category: Primary Care Authors: Soner Cander, Oguzhan Sitki Dizdar, Ozen Oz Gul, Metin Guclu, Oguz Kaan Unal, Ercan Tuncel, Erdinc Erturk, Sazi Imamoglu, Canan Ersoy Source Type: research